UFLEX Limited (UFLEX)
Investor Presentation
Investor Presentation - Q2 FY27
- Consolidated revenue grew 26.1% YoY to Rs. 48,694 Mn; normalized EBITDA rose 94.8% YoY to Rs. 7,588 Mn with 15.6% margin (+550 bps YoY)
- Normalized PAT surged 682.8% YoY to Rs. 2,106 Mn; H1 FY27 revenue up 31.9% YoY, normalized EBITDA +85.7% to Rs. 15,961 Mn
- Capex of Rs. 5,689 Mn in Q2 FY27; major projects include Egypt aseptic plant commissioning in H2 FY27
- Packaging films volume grew 3.0% YoY; growth led by MEA, Americas, and India
- Chairman and CFO highlighted resilience amid geopolitical headwinds and focus on sustainable growth
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 UFLEX — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add UFLEX to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on UFLEX Limited
Important.
The summary above is generated automatically from UFLEX Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.